Literature DB >> 1648384

Ligand-binding domain of thyroid hormone receptors modulates DNA binding and determines their bifunctional roles.

X K Zhang1, K N Wills, G Graupner, M Tzukerman, T Hermann, M Pfahl.   

Abstract

We report here that the thyroid hormone receptors TR alpha and TR beta, and the retinoic acid receptor, RAR, can bind cooperatively to the thyroid hormone response elements (TRE) in both the presence and absence of ligand. Although the transcriptional synergism induced by such cooperative DNA binding could also be influenced by the position of the DNA-binding site on the promoter, the strength of the receptor-DNA interaction in the absence of the cognate ligand of each receptor was in general correlated with the repression activity. The strong-binding TRs, but not the weaker-binding RAR, allowed repression of a constitutive promoter. In addition, strong-binding receptors could repress transcriptional activation of weaker-binding receptors on the TRE. We also show here that the presence of thyroid hormone affects the cooperative DNA binding of TR beta to a TRE dimer by increasing the dissociation rate and decreasing the association rate of TR beta with the DNA. Hybrid receptor analysis revealed that receptor-DNA interaction and repressor activity are largely influenced by the ligand-binding domain of the receptor. We used deletion analysis to localize the sequences conferring a negative effect of thyroid hormone on TR beta binding to DNA and on receptor dimerization or oligomerization. Our data indicate that the ligand-binding domain of thyroid hormone receptors has an essential role in DNA binding and repressor functions, and that this domain exerts its effects by controlling receptor dimerization and oligomerization in the absence and presence of ligand.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648384

Source DB:  PubMed          Journal:  New Biol        ISSN: 1043-4674


  13 in total

1.  Terminal differentiation in keratinocytes involves positive as well as negative regulation by retinoic acid receptors and retinoid X receptors at retinoid response elements.

Authors:  B J Aneskievich; E Fuchs
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

2.  Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors.

Authors:  Michael L Goodson; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

3.  A Purkinje cell protein-2 intronic thyroid hormone response element binds developmentally regulated thyroid hormone receptor-nuclear protein complexes.

Authors:  S G Hagen; R J Larson; K A Strait; J H Oppenheimer
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily.

Authors:  R Apfel; D Benbrook; E Lernhardt; M A Ortiz; G Salbert; M Pfahl
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

5.  A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).

Authors:  F Saatcioglu; P Bartunek; T Deng; M Zenke; M Karin
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

6.  Thyroid hormone receptor can modulate retinoic acid-mediated axis formation in frog embryogenesis.

Authors:  D E Banker; R N Eisenman
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

7.  Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.

Authors:  Y Hayashi; T Sunthornthepvarakul; S Refetoff
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

8.  RAR gamma 2 expression is regulated through a retinoic acid response element embedded in Sp1 sites.

Authors:  J M Lehmann; X K Zhang; M Pfahl
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

9.  Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities.

Authors:  X K Zhang; K N Wills; M Husmann; T Hermann; M Pfahl
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

10.  New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone.

Authors:  P M Yen; A Sugawara; S Refetoff; W W Chin
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.